Pharmaceutical preparations for the detection and research of neurodegenerative diseases and disorders; Diagnostic biomarker reagents for medical purposes; Antibodies for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurodegenerative diseases and disorders; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing